版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡介
1、( (衛(wèi)生經(jīng)濟(jì)學(xué)課件衛(wèi)生經(jīng)濟(jì)學(xué)課件)CEA)CEA7Components of economic evaluation in health careHealth care programResources consumedCost Consequences Health care sector Patient & familyOther sectors Valuation Measurement Identification Resources saved Other value created Health state changed Effects Utility WTP Global W
2、TP Health care sector Patient & familyOther sectors 8Cost-effectiveness analysis Conditions of cost effectiveness analysis What is effectiveness Measure of effectiveness Cost-effectiveness analysis9Conditions of cost effectiveness analysis There is one unambiguous objective of the intervention(s) an
3、d therefore a clear dimension along which effectiveness can be assessed. For example, years of life gained, cases found. There are many objectives, but that the alternative interventions are thought to achieve these to the same extent (cost-minimization analysis). 10What is effectiveness? Effectiven
4、ess is the natural results of a program. it is expressed by natural unit of results, such as life -years saved, cases found, etc.11How to obtain the effectiveness data (1)? Existing medical literature Quality Relevance Case-load, higher selective? Expertise of medical and other staff, double blind?
5、Use placebo? Existence of backup facilities, does the trial require additional tests? Are patients closely monitored?12Levels of evidence and grades of recommendationLevel ofevidenceGrade ofrecommendationLevel ILarge randomised trials withleaver-cut results and low riskof errorGrade ALevel IISmall r
6、andomised trials withuncertain results and moderateto high risk or errorGrade BLevel IIINon-randomised,contemporaneous controlsGrade CLevel IVNon-randomised, historicalcontrolsGrade DLevel VNo controls, case series onlyGrade EAppraisal of the quality of medical evidence13How to deal with more public
7、ations? Meta-analysis or systematic review Principals literature search techniques inclusion/exclusion criteria choice of endpoints records of individual study characteristics details about the therapy tests of statistical homogeneity statistical pooling procedures sensitivity analysis14How to obtai
8、n the effectiveness data (2)? Undertaking economic analysis alongside clinical trials choice of comparison therapy intermediate versus final health outcomes inadequate patient follow-up or sample size protocol-driven costs and outcomes, costs of doing research rather than costs of providing the ther
9、apy clinical trial is usually designed to address safety and efficacy questions, has more strict conditions; however, CEA is to evaluate the costs and effectiveness under the conditions of routine use 15Measure of effectiveness (1) Intermediate health output can project final output Final health out
10、put Linkage of intermediate and final outcomes relative risk observational or case control studies random intervention studies modeling 16Measure of effectiveness (2) Should productivity changes be included? Depend on the viewpoint for the analysis. From a government budget perspective? From a socie
11、tal viewpoint? How to measure the productivity changes by average wage or by gross earnings? Double-counting problem. Less likely in CEA. Equity consideration expressing productivity changes as the number of days of work or normal activity lost or gained, not dollar amount using a general wage rate,
12、 not the actual wages of individuals affected by the programme.17Measure of effectiveness (3) Effectiveness discounting Against: not make sense in the context of health For: leaving effects undiscounted leads to quite impossible conclusions, not reasonable if only discounting costs, not effects. The
13、 current state suggests the effects should be treated in the same way as costs, and discounted at the same rate. So It is advisable to set out all the consequences and costs in the years in which they occur and to present them undiscounted, so that different discount rates can be used.18Cost-effecti
14、veness analysis Cost per unit output Incremental cost-effectiveness analysisProgramme Costs ($)No. of correctdiagnosis$ per correctdiagnosisMethod A3214881422264Method Aplus anothertest if A isnegative6035522013003Increment28206459478119Sensitivity analysis (1) Identify the uncertain parameters a nu
15、mber of sources of uncertainty no data may be available and informed guesses are required imprecise estimation value judgements may be incorporated, e.g. choice of discount rate, etc. generalisability of study results to other settings all variables are potential candidates for sensitivity analysis
16、giving the reasons why particular variables are not included.20Sensitivity analysis (2) Specify the plausible range over which uncertain factors reviewing the literature consulting expert opinion confidence interval around the mean21Sensitivity analysis (3) Calculate study results based on combinati
17、ons of the best guess, most conservative, and least conservative estimates. one-way analysis: to estimate for each parameter multi-way analysis: more than one parameter is uncertain scenario analysis: the best guess scenario, the most optimistic (best case) scenario, the most pessimistic (worst case
18、) scenario. threshold analysis, increasing costs of one or several parameters above which the programme would not be acceptable22Exercise one Suppose one were evaluating two programmes in the field of mental health. One programme requires institutionalisation of the patient for a given period; the other, being a community-based programme using community psychiatric nurses in association with outpatient hospital visits, mean that patients can remain in their own homes. Please identify, measure, value and compare the costs and effectiveness.23Exercise two Assume you ha
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 塑料襯里復(fù)合鋼管和管件結(jié)構(gòu)型式、主要尺寸及基本參數(shù) 編制說明
- Unit 6 Would you like to take a trip?Lesson 32(教案)-2023-2024學(xué)年人教精通版英語四年級下冊
- 2022年廣西梧州中考滿分作文《家的味道》
- Unit 12 Do you have any money?(教學(xué)設(shè)計(jì))-2023-2024學(xué)年湘少版(三起)英語四年級下冊
- Unit 3 Our hobbies Topic 3 Section A 教學(xué)設(shè)計(jì) 2023-2024學(xué)年仁愛版八年級英語上冊
- 專題7 極值點(diǎn)偏移問題2023-2024學(xué)年新教材高中數(shù)學(xué)選擇性必修第二冊同步教學(xué)設(shè)計(jì) (湘教版2019)
- 實(shí)踐是檢驗(yàn)真理的唯一標(biāo)準(zhǔn)教案 人教版
- 6 蠶的一生(教學(xué)設(shè)計(jì))-2023-2024學(xué)年三年級下冊科學(xué)教科版
- 4 改變運(yùn)輸?shù)能囕?教學(xué)設(shè)計(jì) -2024-2025學(xué)年科學(xué)六年級上冊教科版
- 古詩詞誦讀《擬行路難(其四) 》《客至》聯(lián)讀教學(xué)設(shè)計(jì) 2023-2024學(xué)年統(tǒng)編版高中語文選擇性必修下冊
- 機(jī)器設(shè)備評估 第2版 課件 項(xiàng)目八 成本法評估機(jī)器設(shè)備
- QCT957-2023洗掃車技術(shù)規(guī)范
- 2024-2029年中國稀土永磁材料行業(yè)市場分析及市場格局與發(fā)展趨勢預(yù)測研究報(bào)告
- 木材的質(zhì)量檢測與標(biāo)準(zhǔn)
- HYT 083-2005 海草床生態(tài)監(jiān)測技術(shù)規(guī)程
- 2024年江蘇省南京市秦淮區(qū)中考物理一模試卷
- 泌尿系結(jié)石的護(hù)理查房
- 2024年浙江交工集團(tuán)招聘筆試參考題庫附帶答案詳解
- 中考?xì)v史教材知識梳理模塊七湖南地方文化常識新中國的湘籍建國元勛與英雄人物省公開課一等獎百校聯(lián)賽賽課微
- 公務(wù)用車車輛安全培訓(xùn)課件
- 2023年全國行業(yè)職業(yè)技能競賽大賽養(yǎng)老護(hù)理員職業(yè)競賽項(xiàng)目參考賽題庫
評論
0/150
提交評論